is mounjaro glp 1 drug Diabetes Patients Also Struggle to Access GLP-1 Agonists Mounjaro vs. Ozempic: What's the

Queiroz VNF, Falsarella PM, Chaves RCF, Takaoka F, Socolowski LR, Garcia RG

GLP-1RAs reduce events linked to atherogenic cardiovascular disease (especially ischemic stroke) and also renal outcomes (FLOW trial with semaglutide), with a limited effect on heart failure

So cardiologists will need to counsel patients through that and acclimate them to giving these drugs by subcutaneous injection. His colleague Dennis Bruemmer, MD, PhD, Director of Cleveland Clinics Center for Cardiometabolic Health, already has considerable experience using these drugs for diabetes and weight loss

Cardiovascular safety of sulfonylureas: a meta-analysis of randomized clinical trials

Injectable GLP-1 RAs like liraglutide, semaglutide, and dulaglutide have been shown to significantly lower HbA1c and body weight in patients with T2DM